Nahdi Medical (4164) Stock Overview
Operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
4164 Community Fair Values
Create NarrativeSee what 44 others think this stock is worth. Follow their fair value or set your own to get alerts.
Nahdi Medical Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س121.60 |
| 52 Week High | ر.س132.10 |
| 52 Week Low | ر.س106.00 |
| Beta | 0.23 |
| 1 Month Change | 4.02% |
| 3 Month Change | -6.82% |
| 1 Year Change | -6.32% |
| 3 Year Change | -38.96% |
| 5 Year Change | n/a |
| Change since IPO | -18.93% |
Recent News & Updates
Nahdi Medical Company (TADAWUL:4164) Looks Inexpensive But Perhaps Not Attractive Enough
Sep 10
Nahdi Medical's (TADAWUL:4164) Dividend Will Be SAR2.60
Aug 05Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Jun 15Recent updates
Nahdi Medical Company (TADAWUL:4164) Looks Inexpensive But Perhaps Not Attractive Enough
Sep 10Nahdi Medical's (TADAWUL:4164) Dividend Will Be SAR2.60
Aug 05Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Jun 15Nahdi Medical Company Just Recorded A 10% Revenue Beat: Here's What Analysts Think
May 11Investors Aren't Buying Nahdi Medical Company's (TADAWUL:4164) Earnings
May 08Some May Be Optimistic About Nahdi Medical's (TADAWUL:4164) Earnings
Mar 21Nahdi Medical (TADAWUL:4164) Has Affirmed Its Dividend Of SAR3.00
Mar 13Investors Aren't Buying Nahdi Medical Company's (TADAWUL:4164) Earnings
Feb 04Returns On Capital Signal Tricky Times Ahead For Nahdi Medical (TADAWUL:4164)
Oct 18Nahdi Medical Company's (TADAWUL:4164) Share Price Is Matching Sentiment Around Its Earnings
Sep 13Nahdi Medical Company Beat Revenue Forecasts By 6.2%: Here's What Analysts Are Forecasting Next
Aug 07Nahdi Medical (TADAWUL:4164) Has Announced A Dividend Of SAR2.50
Aug 03Capital Allocation Trends At Nahdi Medical (TADAWUL:4164) Aren't Ideal
Jun 18There's No Escaping Nahdi Medical Company's (TADAWUL:4164) Muted Earnings
Apr 25Nahdi Medical (TADAWUL:4164) Is Paying Out A Dividend Of SAR3.00
Mar 21The Returns On Capital At Nahdi Medical (TADAWUL:4164) Don't Inspire Confidence
Jan 07Analyst Estimates: Here's What Brokers Think Of Nahdi Medical Company (TADAWUL:4164) After Its First-Quarter Report
Aug 07Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Jul 25Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Mar 22Nahdi Medical Company's (TADAWUL:4164) Price Is Out Of Tune With Earnings
Dec 13We Think Nahdi Medical's (TADAWUL:4164) Profit Is Only A Baseline For What They Can Achieve
Aug 20Are Investors Undervaluing Nahdi Medical Company (TADAWUL:4164) By 27%?
Aug 01Shareholder Returns
| 4164 | SA Consumer Retailing | SA Market | |
|---|---|---|---|
| 7D | 6.9% | 2.8% | -0.8% |
| 1Y | -6.3% | -23.9% | -8.7% |
Return vs Industry: 4164 exceeded the SA Consumer Retailing industry which returned -23.9% over the past year.
Return vs Market: 4164 exceeded the SA Market which returned -8.7% over the past year.
Price Volatility
| 4164 volatility | |
|---|---|
| 4164 Average Weekly Movement | 3.7% |
| Consumer Retailing Industry Average Movement | 3.7% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in SA Market | 7.5% |
| 10% least volatile stocks in SA Market | 2.5% |
Stable Share Price: 4164 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 4164's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Yasser Bin Abdulaziz Joharji | nahdi.sa |
Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as health and wellness, mom and baby, beauty, and everyday essential products through retail and online stores; and omni-health services, including polyclinics, telemedicine services, labs, and home healthcare. It is also involved in the wholesale and retail trade of cosmetics, pharmaceuticals, special and health food, and medical equipment.
Nahdi Medical Company Fundamentals Summary
| 4164 fundamental statistics | |
|---|---|
| Market cap | ر.س16.16b |
| Earnings (TTM) | ر.س833.61m |
| Revenue (TTM) | ر.س9.88b |
Is 4164 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4164 income statement (TTM) | |
|---|---|
| Revenue | ر.س9.88b |
| Cost of Revenue | ر.س6.32b |
| Gross Profit | ر.س3.56b |
| Other Expenses | ر.س2.73b |
| Earnings | ر.س833.61m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.41 |
| Gross Margin | 36.03% |
| Net Profit Margin | 8.44% |
| Debt/Equity Ratio | 0% |
How did 4164 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/02 13:20 |
| End of Day Share Price | 2025/10/02 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nahdi Medical Company is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ilya Ogorodnikov | BofA Global Research |
| Duaa AlFadda | BofA Global Research |
| Michel Salameh | Citigroup Inc |